









Markets
/
Stocks
/
nasdaq-coep
/

Coeptis Therapeutics Holdings Inc

COEP

11.550USD

+0.830+7.74%

Close 08/04, 16:00（ET）Quotes delayed by 15 min

38.87MMarket Cap

LossP/E TTM



Coeptis Therapeutics Holdings Inc

11.550

+0.830+7.74%

Overview Company Financials

Overview

Company

Financials

Statements

Income Statement

Balance Sheet

Cash Flow Statement

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

FY2021Q3

FY2021Q2

FY2021Q1

FY2020Q3

Operating cash flows (indirect method)

Cash flow from continuing operating activities

-24.38%-2.37M

15.19%-1.44M

3.36%-1.89M

25.50%-1.42M

-12.94%-1.90M

48.85%-1.69M

-2684.83%-1.96M

-643.20%-1.90M

-607.84%-1.68M

-1736.76%-3.31M

-17.50%-70.32K

-109.52%-256.04K

-69.38%-237.97K

---180.29K

-119594.00%-59.85K

---122.20K

---140.50K

---50.00

Net income from continuing operations

-13.98%-3.42M

25.16%-3.01M

70.79%-1.83M

2.50%-3.04M

61.85%-3.00M

90.00%-4.02M

-1952.04%-6.26M

-1420.38%-3.11M

-347.06%-7.87M

-3208.13%-40.25M

-107.30%-305.11K

88.65%-204.75K

-77.37%3.18M

---1.22M

8353918.00%4.18M

---1.80M

--14.07M

---50.00

Operating gains losses

22.02%305.30K

328.23%1.07M

11.15%278.23K

-0.04%250.21K

-75.00%250.31K

--250.31K

--1.00M

----

Other non-cash items

38.39%968.62K

-25.29%445.87K

-99.08%49.50K

-45.32%635.60K

-83.45%699.90K

-98.14%596.76K

9136.87%5.37M

--1.16M

--4.23M

--32.06M

--58.10K

----

Change in working capital

-241.08%-220.75K

-116.20%-196.66K

-176.17%-138.82K

-74.41%53.48K

-19.78%156.48K

167.39%1.21M

-61.47%182.26K

-64.97%209.04K

7.28%195.05K

-1836.10%-1.80M

1078.17%473.08K

1684.34%596.72K

17724.61%181.81K

--103.79K

--40.15K

--33.44K

--1.02K

--0.00

-Change in receivables

----

--0.00

-100.00%0.00

100.00%0.00

--0.00

--8.08K

---8.08K

----

-Change in prepaid expenses

188.03%135.78K

-2062.45%-275.35K

55.47%65.06K

215.33%44.69K

127.63%47.14K

102.91%14.03K

93.19%41.84K

21.52%14.17K

149.16%20.71K

-4761.75%-481.88K

-22.98%21.66K

-62.16%11.66K

-63.30%-42.13K

--10.34K

--28.12K

--30.82K

---25.80K

----

-Change in other current liabilities

---62.87K

--235.00K

----

Cash from non-recurring investing activities

Cash from operating activities

-24.38%-2.37M

15.19%-1.44M

3.36%-1.89M

25.50%-1.42M

-12.94%-1.90M

48.85%-1.69M

-2684.83%-1.96M

-643.20%-1.90M

-607.84%-1.68M

-1736.76%-3.31M

-17.50%-70.32K

-109.52%-256.04K

-69.38%-237.97K

---180.29K

-119594.00%-59.85K

---122.20K

---140.50K

---50.00

Investing cash flow

Net cash from continuing investing activities

----

--0.00

----

Capital expenditures

----

--0.00

----

Net cash flow from disposal of fixed assets

----

--0.00

----

Net cash flow from investment products

----

--333.33K

---133.33K

---200.00K

----

Net cash flow from other investing activities

100.00%0.00

--100.00K

-100.00%0.00

100.00%0.00

---100.00K

----

--350.00K

-100.81%-350.00K

----

---43.03M

--0.00

--43.03M

----

Cash from non-current investing activities

Net cash flow from investing activities

100.00%0.00

--100.00K

-100.00%0.00

100.00%0.00

---100.00K

100.00%0.00

362.50%350.00K

-100.82%-350.00K

--0.00

---42.69M

---133.33K

--42.83M

----

Financing cash flow

Cash flow from continuous financing activities

290.51%6.10M

-58.21%731.97K

755.77%1.47M

-42.68%1.94M

--1.56M

-96.35%1.75M

-268.69%-224.93K

107.95%3.39M

--0.00

--48.01M

--133.33K

---42.65M

----

--0.00

Net cash flow from debt Issuance/repayment

-27.41%771.25K

68.27%-63.47K

100.00%0.00

-42.86%200.00K

--1.06M

92.28%-200.00K

-2669.18%-725.00K

75.00%350.00K

--0.00

---2.59M

---26.18K

--200.00K

----

--0.00

-100.00%0.00

--0.00

--21.43K

Net cash flow from common stock issuance/repurchase

-100.00%0.00

-94.29%100.00K

----

-116.44%-500.00K

--500.00K

-79.44%1.75M

--500.07K

--3.04M

--0.00

--8.52M

----

Net cash flow from preferred stock issuance/repurchase

--5.33M

--695.44K

--1.52M

--1.69M

----

Proceeds from stock option exercised by employees

----

---50.00K

--50.00K

----

Proceeds from issuance of warrants

--400.00

-100.00%0.00

--0.00

--500.00K

----

--200.00K

----

---173.82K

--173.82K

----

Net cash flow from other financing activities

----

--42.08M

--333.33K

---43.03M

----

--0.00

100.00%0.00

--0.00

---21.43K

Net cash from non-recurrent financing activities

Net cash from financing activities

290.51%6.10M

-58.21%731.97K

755.77%1.47M

-42.68%1.94M

--1.56M

-96.35%1.75M

-268.69%-224.93K

107.95%3.39M

--0.00

--48.01M

--133.33K

---42.65M

----

--0.00

Net cash flow

Beginning cash balance

-63.73%532.88K

-19.42%1.14M

-52.08%1.56M

-51.15%1.03M

-61.25%1.47M

-21.10%1.41M

3755.85%3.24M

1166.33%2.11M

837.64%3.79M

206.01%1.79M

-86.94%84.15K

-78.30%166.37K

-55.43%404.35K

--584.63K

180426.89%644.48K

--766.69K

--907.18K

--357.00

Current period cash flow changes

949.19%3.74M

-1149.16%-604.57K

77.22%-417.62K

-53.79%525.83K

73.89%-439.89K

-97.12%57.62K

-2506.97%-1.83M

1484.07%1.14M

-607.84%-1.68M

1210.58%2.00M

-17.50%-70.32K

32.72%-82.22K

-69.38%-237.97K

---180.29K

-119594.00%-59.85K

---122.20K

---140.50K

---50.00

Ending cash balance

314.71%4.27M

-63.73%532.88K

-19.42%1.14M

-52.08%1.56M

-51.15%1.03M

-61.25%1.47M

10106.15%1.41M

3755.85%3.24M

1166.33%2.11M

837.64%3.79M

-97.63%13.83K

-86.94%84.15K

-78.30%166.37K

--404.35K

190334.53%584.63K

--644.48K

--766.69K

--307.00

Free cash flow

-24.38%-2.37M

---1.44M

3.36%-1.89M

25.50%-1.42M

-12.94%-1.90M

----

-2684.83%-1.96M

-643.20%-1.90M

---1.68M

---3.31M

---70.32K

---256.04K

----

Currency unit

USD

Audit opinions

KeyAI

